Biomarkers in Multiple Sclerosis: From an Early Diagnosis to an Accurate Prognosis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 24170
Special Issue Editor
Interests: multiple sclerosis; MRI; cerebro-spinal fluid; biomarkers; artificial intelligence
Special Issue Information
Dear Colleagues,
Although the early diagnosis and treatment of multiple sclerosis is associated with better patient outcomes, many people remain undiagnosed or are initially misdiagnosed. Furthermore, the identification of patients at high risk of disease activity and disability progression is still a major unmet therapeutic aim.
The aim of this Special Issue is to shed light on the new biomarkers which can help physicians in making the diagnostic work-up more accurate while also improving the accuracy in predicting disease activity, disability progression, and treatment efficacy. Clinical (both physical and cognitive), radiological, and biological diagnostic or prognostic markers will be welcome.
Original papers and reviews will be accepted.
Prof. Dr. Massimiliano Calabrese
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- biomarkers
- diagnosis and prognosis
- MRI
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.